We would appreciate it if you could complete our website survey, open until 28 November 2025.
This item is authorised by the following title:
There is no text version of the title available for this point-in-time. Other point-in-time versions of this title may be available.
View the versions for this title.
Please send a request to OPC using our feedback form to add this version of the Designation of Selexipag as an Orphan Drug - Actelion Pharmaceuticals Australia Pty Ltd (30 September 2014) to our back capture version creation priority list.
